Early Detection Research Network

Next generation sequencing of prostate cancer from a patient identifies a deficiency of methylthioadenosine phosphorylase, an exploitable tumor target.

No abstract available.

Anderson S, Bell RH, Beltran H, Bertino JR, Brahmbhatt S, Cheng H, Chinnaiyan AM, Collins CC, Demichelis F, Fazli L, Gleave M, Gout PW, Haegert A, Hirst M, Hurtado-Coll A, Lapuk AV, Lubin M, Maher CA, Marra M, Rubin MA, Volik SV, Wang Y, Wang Y, Wu C, Xue H


Mol. Cancer Ther., 2012, 11 (3)